# 2025-15115: DEA Approves Bulk Production of Controlled Substances for Chemtos, LLC

2025-15115, Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-08-08 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-15115
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-15115
- Title: Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 38502
- Published: 2025-08-08
- Effective: unknown
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

DEA Approves Bulk Production of Controlled Substances for Chemtos, LLC

## Summary

Chemtos, LLC wants to get official approval to make large amounts of certain controlled substances. This affects anyone tracking or regulating these drugs and could impact how these substances are produced and monitored. Keep an eye out for updates on their application status and any new rules that might come with it!

## Abstract

Chemtos, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-15115 on federalregister.gov](https://www.federalregister.gov/documents/2025/08/08/2025-15115/bulk-manufacturer-of-controlled-substances-application-chemtos-llc)
- [2025-15115 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-08-08/pdf/2025-15115.pdf)

## Related
- [Previous: 2025-15114, Agency Information Collection Activities; Submission to the Office of Managemen…](https://policyrisk.com/federal-register/2025-15114)
- [Next: 2025-15116, Agency Information Collection Activities; Information Collection Renewal; Comme…](https://policyrisk.com/federal-register/2025-15116)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-15115 (as of 2026-06-08).
